Literature DB >> 8321856

Deposition patterns of aerosolized drugs within human lungs: effects of ventilatory parameters.

T B Martonen1, I M Katz.   

Abstract

A mathematical model for inhaled aerosolized drugs is validated by comparisons of predicted particle deposition values with experimental data from adult subject inhalation exposure tests. The model is subsequently used to study the effects of ventilatory parameters on particle deposition patterns within the human lung. By altering breathing profiles, deposition values can be affected regarding quantity delivered and spatial location. Increased tidal volumes and breath-holding times increase deposition in the pulmonary region, while increased inspiratory flow rates increase deposition in the tracheobronchial region. Based upon fluid dynamics considerations (Reynolds numbers), an original method of partitioning the lung is also presented. The model has implications with regard to aerosol therapy, indicating that the efficacies of inhaled pharmacological drugs in the prophylaxis and treatment of airway diseases can be improved by regulating breathing profiles to deposit particles selectively at prescribed sites within the lung.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8321856     DOI: 10.1023/a:1018913311788

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  21 in total

1.  Deposition of aerosol particles in the human nose.

Authors:  J Heyder; G Rudolf
Journal:  Inhaled Part       Date:  1975-09

2.  Localization of beta-adrenoreceptors in mammalian lung by light microscopic autoradiography.

Authors:  P J Barnes; C B Basbaum; J A Nadel; J M Roberts
Journal:  Nature       Date:  1982-09-30       Impact factor: 49.962

3.  Analytical model of hygroscopic particle behavior in human airways.

Authors:  T B Martonen
Journal:  Bull Math Biol       Date:  1982       Impact factor: 1.758

4.  Distribution of bronchodilatation in normal subjects: beta agonist versus atropine.

Authors:  M J Hensley; C F O'Cain; E R McFadden; R H Ingram
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1978-11

5.  Human subject age and activity level: factors addressed in a biomathematical deposition program for extrapolation modeling.

Authors:  T B Martonen; R C Graham; W Hofmann
Journal:  Health Phys       Date:  1989       Impact factor: 1.316

6.  The effects of preferential deposition of histamine in the human airway.

Authors:  R E Ruffin; M B Dolovich; R K Wolff; M T Newhouse
Journal:  Am Rev Respir Dis       Date:  1978-03

7.  Increased lung deposition and biological effect of methacholine by use of a drying device for bronchial provocation tests.

Authors:  P Malmberg; K Larsson; S Thunberg
Journal:  Eur Respir J       Date:  1991-07       Impact factor: 16.671

8.  Effect of particle size of bronchodilator aerosols on lung distribution and pulmonary function in patients with chronic asthma.

Authors:  D M Mitchell; M A Solomon; S E Tolfree; M Short; S G Spiro
Journal:  Thorax       Date:  1987-06       Impact factor: 9.139

9.  Aerosolized atropine sulfate: influence of inhalation pattern on effective blockade of vagal airway tone.

Authors:  M L Groth; W M Foster
Journal:  Am Rev Respir Dis       Date:  1992-01

10.  Physical properties and clinical efficacy of two sodium cromoglycate inhalation aerosol preparations.

Authors:  M Vidgren; M Silvasti; P Vidgren; K Laurikainen; H Lehti; P Paronen
Journal:  Acta Pharm Nord       Date:  1991
View more
  9 in total

1.  Airway identification within planar gamma camera images using computer models of lung morphology.

Authors:  Jeffry D Schroeter; John N Pritchard; Dongming Hwang; Ted B Martonen
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

Review 2.  Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities.

Authors:  Sharad Mangal; Wei Gao; Tonglei Li; Qi Tony Zhou
Journal:  Acta Pharmacol Sin       Date:  2017-05-01       Impact factor: 6.150

3.  The acoustic features of inhalation can be used to quantify aerosol delivery from a Diskus™ dry powder inhaler.

Authors:  Jansen N Seheult; Peter O'Connell; Kee Chun Tee; Tariq Bholah; Hasan Al Bannai; Imran Sulaiman; Elaine MacHale; Shona D'Arcy; Martin S Holmes; David Bergin; Emer Reeves; Richard B Reilly; Gloria Crispino-O'Connell; Carsten Ehrhardt; Anne Marie Healy; Richard W Costello
Journal:  Pharm Res       Date:  2014-05-28       Impact factor: 4.200

4.  Small Airway Absorption and Microdosimetry of Inhaled Corticosteroid Particles after Deposition.

Authors:  P Worth Longest; Michael Hindle
Journal:  Pharm Res       Date:  2017-06-22       Impact factor: 4.200

5.  Bioinspired particle engineering for non-invasive inhaled drug delivery to the lungs.

Authors:  Snehal K Shukla; Apoorva Sarode; Dipti D Kanabar; Aaron Muth; Nitesh K Kunda; Samir Mitragotri; Vivek Gupta
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2021-07-15

6.  Aerosol deposition as a function of airway disease: cystic fibrosis.

Authors:  T Martonen; I Katz; W Cress
Journal:  Pharm Res       Date:  1995-01       Impact factor: 4.200

7.  Pulmonary versus systemic delivery of antibiotics: comparison of vancomycin dispositions in the isolated rat lung.

Authors:  María José de Jesús Valle; Francisco González López; Alfonso Domínguez-Gil Hurlé; Amparo Sánchez Navarro
Journal:  Antimicrob Agents Chemother       Date:  2007-08-06       Impact factor: 5.191

8.  Investigating the relationship between peak inspiratory flow rate and volume of inhalation from a Diskus™ Inhaler and baseline spirometric parameters: a cross-sectional study.

Authors:  Jansen N Seheult; Simon Costello; Kee Chun Tee; Tariq Bholah; Hasan Al Bannai; Imran Sulaiman; Richard W Costello
Journal:  Springerplus       Date:  2014-09-02

Review 9.  Inhaled nanomaterials and the respiratory microbiome: clinical, immunological and toxicological perspectives.

Authors:  Tuang Yeow Poh; Nur A'tikah Binte Mohamed Ali; Micheál Mac Aogáin; Mustafa Hussain Kathawala; Magdiel Inggrid Setyawati; Kee Woei Ng; Sanjay Haresh Chotirmall
Journal:  Part Fibre Toxicol       Date:  2018-11-20       Impact factor: 9.400

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.